LungLife AI (LSE:LLAI) Ending Cash Position : £2.06 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Ending Cash Position?

LungLife AI's Ending Cash Position for the quarter that ended in Jun. 2024 was £2.06 Mil.

LungLife AI's quarterly Ending Cash Position increased from Jun. 2023 (£2.05 Mil) to Dec. 2023 (£2.15 Mil) but then declined from Dec. 2023 (£2.15 Mil) to Jun. 2024 (£2.06 Mil).

LungLife AI's annual Ending Cash Position declined from Dec. 2021 (£6.93 Mil) to Dec. 2022 (£2.54 Mil) and declined from Dec. 2022 (£2.54 Mil) to Dec. 2023 (£2.15 Mil).

LungLife AI Ending Cash Position Historical Data

The historical data trend for LungLife AI's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Ending Cash Position Chart

LungLife AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.56

0.10

6.93

2.54

2.15

LungLife AI Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial						4.67	2.54	2.05	2.15	2.06

LungLife AI Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LungLife AI's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.44	+	-0.288
	=	2.15

LungLife AI's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.141	+	-0.082
	=	2.06

LungLife AI Ending Cash Position Related Terms

Thank you for viewing the detailed overview of LungLife AI's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320

Website

https://www.lunglifeai.com

LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI Headlines

No Headlines